American Journal on Addictions

Papers
(The median citation count of American Journal on Addictions is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Issue Information59
AAAP's Annual Meeting and Scientific Symposium26
Stand against stigma25
Self assessment ad (002)24
Barriers for recruitment to treatment of youths with co‐occurring substance use disorders and depression23
Issue Information21
Call for Special Issue 202421
2024 Annual Meeting Posters20
Impact of baseline methamphetamine/amphetamine use on discontinuation of methadone and buprenorphine/naloxone among people with prescription‐type opioid use disorder in Canada19
Availability of substance use disorder treatment in Spanish: Associations with state‐level proportions of Spanish speakers and treatment facility characteristics in the United States19
AAAP 36th Annual Meeting & Scientific Symposium Save the Date18
AAAP Stimulant Use Disorder PIP15
The prevalence and treatment utilization of substance use disorders among Muslims in the United States: A national epidemiological survey15
Gender differences in circumstances associated with cannabis use14
Seeing is believing: How cannabis marketing exposure is associated with cannabis use attitudes and behavior in a permissive medical cannabis policy environment13
Regional differences in fatal drug overdose deaths among Black and White individuals in the United States, 2012–202113
Time spent on social media and depressive symptoms in university students: The mediating role of psychoactive substances13
Improvements in recovery capital are associated with decreased alcohol use in a primary opioid use disorder treatment‐seeking cohort13
AAAP Annual meeting ad12
Issue Information12
Prevalence of problematic Internet use and its association with quality of life among undergraduate nursing students in the later stage of COVID‐19 pandemic era in China11
Become a member of AAAP!10
Emotional regulation in Gaming Disorder: A systematic review10
Narcotics Anonymous members in recovery from methamphetamine use disorder10
Synthetic cannabinoid use and the acquired preparedness model9
Cannabis use disorder and increased risk of arrhythmia‐related hospitalization in young adults9
Call for Review Papers 20249
Identifying factors associated with peer recovery coach interactions and successful outcomes for patients with opioid use disorder in Southern West Virginia9
AM Registration Flyer9
Call for Special Issue Papers 20259
Tobacco use and impulsivity in people with mental illness: A systematic review9
Correlates of optimism among patients in substance use disorder inpatient treatment9
Issue Information ‐ ToC8
Call for review papers 20218
Patient–provider interactions about cannabis for therapeutic purposes vary as a function of provider type: A pilot study8
Call for Special Issue Papers 20248
Does cyber dating abuse victimization predict next‐day alcohol and cannabis use among college students?8
Call for Review Papers 20248
Preconference On‐Demand availability7
7
Issue Information ‐ Editorial Board7
Issue Information ‐ Editorial Board7
Call for review papers 20227
Exploring cannabis as a treatment for chronic pain in a rural Appalachian population6
Extended‐release buprenorphine in pregnancy6
AAAP Podcast EP6
AAAP AATT Preconference6
Marijuana use disorder among adults with functional disabilities—A US population‐based cross‐sectional study6
Posttraumatic stress disorder in Chinese methamphetamine patients: Prevalence, demographics, and clinical correlates6
AJA Annual Meeting 20236
An exploratory analysis of 5‐alpha reductase inhibitors and risk of opioid use disorder among male Medicare beneficiaries receiving prescription opioid medications6
AAAP Call for Abstracts6
Issue Information6
AAAP's Performance in practice activities5
Addiction specialists' attitudes toward psychedelics: A National Survey5
Issue Information ‐ Editorial Board5
Stand Against Stigma5
Differences in intent to refer buprenorphine among community correctional and treatment staff: A set of cross‐lagged models predicting efficacy beliefs and familiarity with buprenorphine for opioid us5
2023 Advanced Addiction Psychopharmacology Course5
AAAP annual meeting and pre‐conference courses5
Personality predicting relapse: A facet analysis of the NEO PI‐R5
Health care service utilization and drug overdose death: A national nested case–control registry study5
Issue Information ‐ ToC5
Call for special issue 20234
Brief report: The influence of childhood trauma on the effects of delta‐9‐tetrahydrocannabinol in persons with opioid use disorder4
State‐level racial and ethnic disparities in buprenorphine treatment duration in the United States4
Cannabis Use Disorders Performance in Practice4
AJA AM Save the Date 20234
Call for Symposium Abstracts4
FREE Live Webinar Psychotherapy Series: CAMS Approach to Suicidal Risk ‐ David A. Jobes, PhD, ABPP (Aug 13, 2025)4
Registration open – AAAP annual meeting and pre‐conference courses4
Call for Special Issue 20234
4
2021 AJA Reviewer List4
Open‐label investigation of rapid initiation of extended‐release buprenorphine in patients using fentanyl and fentanyl analogs4
Effects of persistent cannabis use on depression, psychosis, and suicidality following cannabis‐induced psychosis: A longitudinal study4
A systematic review and meta‐analysis of the relationship between heavy smoking and probability discounting4
2023 Addictions and Their Treatment Course4
Sleep disturbance in clients attending a specialist addiction clinic4
4
AAAP Podcast Episode 10: A Discussion On Cybersecurity With Norma Krayem3
Severe gamma‐hydroxybutyrate withdrawal with delirium, hemodynamic lability, and rhabdomyolysis: A case series3
Become an AAAP Member3
Issue Information ‐ Editorial Board3
3
Sociodemographic profile and clinical presentation of young children unintentionally exposed to marijuana: A single site retrospective cohort3
AJA AM save the date 20233
Brief Report: Expectancies for alcohol analgesia are associated with greater alcohol use among moderate‐to‐heavy drinkers without chronic pain3
Evaluation of real‐world outcomes associated with use of a prescription digital therapeutic to treat substance use disorders3
Drugs and bugs: Negative affect, psychostimulant use and withdrawal, and the microbiome3
Stand Against Stigma3
Mini‐Symposia I3
Save the Date ‐ Annual Meeting 20253
Psychotherapy Webinar Series AJA3
Trends in substance use disorder diagnoses among Veterans, 2009–20193
Anxiety sensitivity and cannabis use motives among trauma‐exposed young adult cannabis users3
Medical Update3
AAAP Membership benefits3
The relationship between depressed affect, parental monitoring, and sex on cannabis use among American Indian youth3
AAAP 2024 Self‐Assessment Exam Now Available3
Substance use treatment services utilization and outcomes among probationers in drug courts compared to a matched cohort of probationers in traditional courts2
Symposium III2
Call for review papers 20222
Daily cannabis use may cause cannabis‐induced hyperalgesia2
2025 Call for Symposium Abstracts2
Unfilled prescriptions: Surveying patients' experiences with buprenorphine treatment in Massachusetts before and during the COVID‐19 pandemic2
Issue Information ‐ Editorial Board2
Gambling, tobacco use, and health among individuals in substance use disorder treatment2
Issue Information2
Symposium I2
2024 Annual Meeting Posters2
ORN Advancing racial equity2
Film & Media Workshop2
Cannabis Use PIP Ad2
Paper sessions2
Concurrent Paper Sessions2
AAAP on‐demand educational activities2
Medication Management for Stimulant Use Disorder Webinar2
Prevalence, demographics, and clinical correlates of antisocial personality disorder in Chinese methamphetamine patients2
Call for special issue 20232
Mini‐Symposia II2
Management of xylazine toxicity, overdose, dependence, and withdrawal: A systematic review2
Addiction Psychiatry Advanced Psychotherapy Curriculum2
Dexmedetomidine HCL (BXCL501) as a potential treatment for alcohol use disorder and comorbid PTSD: A phase 1b, placebo‐controlled crossover laboratory study2
Call for Review Papers 20232
Call for special issue 20232
AAAP Podcast Series, Episode 10: Discussion on Cybersecurity with Norma Krayem2
Cannabis involvement in posttraumatic stress disorder emergency department visits after cannabis legalization1
33rd AAAP Annual Meeting and Scientific Symposium Recap1
32nd AAAP Annual meeting & scientific symposium recap1
Examining family member characteristics by treatment status of the relative with substance use problems1
Understanding the role of cannabis use on cigarette dependence severity among individuals with e‐cigarette and combustible tobacco dual use1
Feasibility and preliminary efficacy of a community support intervention for people with opioid use disorder1
AJA Psychedelics1
Opioid overdose prevention and response training for medical students: Does training provide a benefit beyond the traditional curriculum, and are the gains of early training maintained?1
Legalization of cannabis in Canada—Local media analysis1
AAAP Membership1
AAAP Advanced Addiction Psychopharmacology Virtual Course, October 5‐6, 20241
Issue Information ‐ ToC1
AAAP ORN PIP ad1
Medical Update1
AJA Annual Meeting 20241
Treatment patterns and healthcare resource use among veterans initiating medication for incident moderate‐to‐severe alcohol use disorder1
Characteristics and treatment preferences of individuals with opioid use disorder seeking to transition from buprenorphine to extended‐release naltrexone in a residential setting1
Call for special issue 20231
Opioid use disorder in the active service: Implications for intervention1
Evaluating the substance use disorder treatment gap in the United States, 2016−2019: A population health observational study1
Cannabis and the overdose crisis among US adolescents1
Bupropion XL and SR have similar effectiveness and adverse event profiles when used to treat smoking among patients at a comprehensive cancer center1
PCSS exchange AJA Ad1
Issue Information1
AAAP Pre‐Conference On‐Demand Course ‐ AATT & AAP1
Program title youth substance use and addiction timely updates on a critical issue1
AAAP conference agenda1
Recent trends in prescription drug misuse in the United States by age, race/ethnicity, and sex1
Associations between alcohol and cannabis use order, frequency, quantity, and consequences in a college sample of individuals who co‐use alcohol and cannabis1
Conference Schedule1
Educating the community about the opioid epidemic and medications for opioid use disorder1
Obsessive‐compulsive disorder in Chinese methamphetamine patients: Prevalence, demographics, and clinical characteristics1
Addiction Psychiatry Advanced Psychotherapy Curriculum1
2023 Advanced Addiction Psychopharmacology Course1
Alcohol use and alcohol‐related consequences based on gender and sexual orientation among college students1
Trajectories of prescription opioid and heroin use in adulthood0
AAAP Psychotherapy Curriculum Series0
Dissociation of drug and negative emotional cue induced attentional bias in individuals with methamphetamine‐use disorder0
Variables associated with methamphetamine use within the past year and sex differences among patients with methamphetamine use disorder: A cross‐sectional study in Japan0
Issue Information ‐ ToC0
FREE Training & Mentoring: PCSS and ORN0
AAAP_Call for Review papers‐20240
Associations of methadone and buprenorphine‐naloxone doses with unregulated opioid use, treatment retention, and adverse events in prescription‐type opioid use disorders: Exploratory analyses of the O0
Characteristics of xylazine‐related deaths in West Virginia—Xylazine‐related deaths0
Travel Award AJA0
FREE Online Self‐Assessment Exam: ORN StUD Performance in Practice (PIP)0
Call for special issue 20210
Is your AAAP membership expiring soon?0
AAAP podcast0
AAAP Travel Awards Open0
Provider–patient relationships and trauma among pregnant patients with opioid‐use disorder0
Motivational Interviewing PIP0
Effects of a trauma‐informed mindful recovery program on comorbid pain, anxiety, and substance use during primary care buprenorphine treatment: A proof‐of‐concept study0
Discrimination experiences and problematic alcohol and cannabis use in young adulthood0
Call for review papers 20230
AAAP Podcast0
Issue Information0
Two‐part models identifying predictors of cigarette, e‐cigarette, and cannabis use and change in use over time among young adults in the US0
Call for Review Papers 20240
Stand against stigma0
Issue Information0
Issue Information ‐ Editorial Board0
0
AAAP PIPS 20230
Estimating the effects of prenatal cannabis exposure on birth outcomes0
Binge drinking and sexual risk behavior among US sexual and gender minority college students0
Alcohol and marijuana co‐use among adults with chronic low back pain: Associations with substance misuse, mental health, and pain experience0
AAAP Performance and Practice (PIP) Resources0
Faith leaders’ perceptions of needle exchange programs in the rural Illinois Delta Region: Religion as a social determinant of health0
Does tobacco dependence worsen cannabis withdrawal in people with and without schizophrenia‐spectrum disorders?0
Impact of state and trait anxiety severity on retention and phase advancement in an outpatient buprenorphine treatment program0
0
Film & Media Workshop0
Factors associated with dual and polytobacco use among people in residential substance use disorder treatment0
Symposia, Medical Update, and Case Conference0
Symposium IV0
Trajectories of depression among patients in treatment for opioid use disorder: A growth mixture model secondary analysis of the XBOT trial0
Medical marijuana access and prolonged opioid use among adolescents and young adults0
Issue Information ‐ Editorial Board0
Psychotherapy Webinar Series AJA0
Clinical and psychosocial outcomes by sex among individuals prescribed buprenorphine‐naloxone (BUP‐NX) or extended‐release naltrexone (XR‐NTX) for opioid use disorder0
2022 Self‐Assessment examination0
Issue Information0
Is buprenorphine maternal dose associated with neonatal opioid withdrawal syndrome severity?0
2023 Reviewer List (n = 223)0
PCSS is here to help!0
Identifying treatment responders to the combination of varenicline and naltrexone0
Opioid agonist treatment outcomes among individuals with a history of nonfatal overdose: Findings from a pragmatic, pan‐Canadian, randomized control trial0
AAAP's Educational Offerings0
Reasons for electronic cigarette use: Differences based on sex and young adult status0
Issue Information0
0
Addiction Psychiatry Advanced Psychotherapy Session, September 11, 20240
Racial and ethnic differences in self‐reported barriers to substance use treatment among emergency department patients0
ORN Consultant Recruitment ‐ Join A National Public Health Alliance0
Absorption of naloxone in patients prescribed buprenorphine‐naloxone0
Issue Information0
Issue Information0
Cognitive improvement among abstinent methamphetamine users: A 2‐year prospective longitudinal study0
Call for Special Issue 20220
Pain intensity in patients using extended‐release naltrexone or opioid agonists and its effect on extended‐release naltrexone treatment outcomes0
Issue Information ‐ Editorial Board0
Become a AAAP Member0
Registration Open Now: Virtual Courses on Addictions and Their Treatment (Sep 12–13, 2025) and Advanced Addiction Psychopharmacology (Sep 20–21, 2025)0
CSAM 2021 scientific conference0
The impact of body image dissatisfaction on psychological distress and health‐related quality of life among patients in methadone treatment0
An examination of cannabis use motives among couples with intimate partner violence and alcohol use disorder0
Become A AAAP Member!0
Symposium II0
AJA psychedelic Ad0
Levels of engagement among office‐based opioid treatment (OBOT) patients with concurrent methamphetamine use0
Call for review papers 20230
Motives for prescription opioid use: The role of alexithymia and distress tolerance0
Opioid use disorder and its association with self‐reported difficulties participating in social activities0
Are DEA‐waivered buprenorphine prescribers colocated with behavioral health clinicians?0
Serum brain‐derived neurotrophic factor in relation to craving and duration of abstinence in patients with heroin dependence—A case‐control study0
Food insecurity risk and alcohol use disorder in US young adults: Findings from the National Longitudinal Study of Adolescent to Adult Health0
Age and gender differences in motives for z‐drug misuse: Findings from the 2015 to 2019 NSDUH survey0
2024 Reviewer List0
Gender differences in the prevalence of stimulant misuse in the United States: 2015–20190
CSAM‐SMCA 2022 Scientific conference and annual meeting0
Polysubstance use profiles among US adults using Kratom (Mitragyna speciosa): A latent class analysis using The National Survey on Drug Use and Health (NSDUH)0
Become a AAAP Member0
0.066591024398804